An analysis of 295 breast cancer patients revealed that higher expression of PRAME was associated with poorly differentiated tumours, and PRAME expression was related to ER levels, as ER-negative patients had higher PRAME expression, whereas ER-positive patients had low PRAME expression [58]. This evidence concerns the gene PRAME and breast cancer.